Researchers develop a simplified method to modify disease signaling with light

Researchers develop a simplified method to modify disease signaling with light
Expression of optogenetic actuators in neurons allows precise non-invasive control of signalling pathways using light pulses. This permits a better understanding of pathway modified in neurological disorders. Credit: Nature Communications

Most diseases are caused by aberrant cell signaling processes, and basic research in cell signaling is needed to identify targets for future therapeutic approaches, especially in cases where no cures or effective treatments are currently available.

Cellular optogenetics uses light to precisely control in space and over time, making it an invaluable technique for disease research. However, this potentially revolutionary method has been difficult for many researchers to use as, over long periods of time, the used light can itself have adverse effects on biological systems and the can inactivate unexpectedly rapidly.

Now, researchers from the University of Turku in Finland, in collaboration with Frankfurt University Hospital in Germany, have developed a novel way to harness the quantum mechanical phenomenon of resonance energy transfer to design optogenetic tools that are more sensitive to light. The new method also informs the user exactly when an optogenetic tool is going to inactivate in cells. If continued activity is required, just the right amount of additional can then be re-applied to re-activate the .

Combining these advances with existing tools and knowledge, the researchers were able to design and build more efficient optogenetic tools to investigate signaling pathways. With the improved tools, they studied two common chemotherapy drugs known to cause side effects on neurons and cause . The new tools revealed how both activatory and inhibitory pathways contribute to the actions of these drugs on the investigated disease-associated pathway.

"Now we can develop more powerful tools to understand precisely how harmful conditions disrupt signaling in living . This information is likely to help us in identifying targets and designing better therapeutic compounds for conditions such as chemotherapy-induced neuropathic pain," says Lili Li, the lead author of the study and Postdoctoral Researcher at the Turku Bioscience Centre.

"There is still considerable potential to further exploit these quantum mechanical phenomena to devise even better quantitative and informative methods in biology and medicine, which could support the future discovery of new therapeutic approaches," adds senior author of the study Michael Courtney.

Explore further

A new tool for switching proteins on and off

More information: Li-Li Li et al. Resonance energy transfer sensitises and monitors in situ switching of LOV2-based optogenetic actuators, Nature Communications (2020). DOI: 10.1038/s41467-020-18816-8
Citation: Researchers develop a simplified method to modify disease signaling with light (2020, October 22) retrieved 18 January 2022 from
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Feedback to editors